Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol vs oxycodone for postoperative moderate to severe pain
CTR20221963Phase 3Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tapentadol in postoperative pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Aug 2022; status: completed.
02
Drugs
tapentadol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20221963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221963.